← Leaderboards
Jill P Buyon
New York University School Of Medicine
$29,367,681
Attributed
$50,131,837
Total exposure
31
Grants
21
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.5M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$53,183,053 · 31
CDC$3,649,997 · 1
By mechanism
R01$22,542,320 · 9
P50$7,521,716 · 2
U01$6,392,800 · 2
UH2$6,349,061 · 1
UC2$5,148,251 · 1
R37$4,000,911 · 1
Top collaborators
- Chaim Putterman11 shared
- Thomas Tuschl11 shared
- Jeffrey S Berger8 shared
- Peter Izmirly8 shared
- Boris Reizis7 shared
- Bettina Francesca Cuneo6 shared
- Michelle A Petri6 shared
- Brad H Rovin6 shared
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Bettina Francesca Cuneo$2,235,390
- Wilnelly Martinez-Ortiz$163,379
- Peter Izmirly$3,742,276
- Paraskevi Briasouli$346,843
- Ryan Comfort Branski$7,514,357
Others in their field
Top investigators on “Systemic Lupus Erythematosus”
- Ignacio E. Sanz · University Of Rochester$57,737,718
- George C Tsokos · Beth Israel Deaconess Medical Center$37,219,358
- David Wofsy · University Of California, San Francisco$36,472,228
- Betty Diamond · Feinstein Institute For Medical Research$32,406,714
- John Barker Harley · Cincinnati Va Medical Center Research$30,355,689
- Patrick M Gaffney · University Of Minnesota Twin Cities$27,964,103
Research focus
Systemic Lupus ErythematosusPhenotypeTissuesMediatingAutoantibodiesEvaluationAffectPathway InteractionsResponseCellsPathogenesisOrganEnrollmentAutoimmunityImmunoglobulin GWomanLupusBaseInflammationTranslational ResearchInsightMedical SchoolsSignal TransductionSite
Grant awards (120)
Lupus Omics Cutaneous Kidney Investigative Team (LOCKIT)$1,249,871
UC2 · FY2025 · AR · contact PI
DP22-002 HEALTH: Harnessing Epidemiology to Advance Lupus Treatment and Health$899,999
U01 · FY2025 · DP
Atrioventricular Block Elimination by Rozanolixizumab Treatment$755,461
R01 · FY2025 · AR · contact PI
Mechanisms of DNA-Specific Autoimmunity in Systemic Lupus Erythematosus$629,341
R01 · FY2025 · AR
Digital Pathology and Computational Image Analysis for Lupus Nephritis$604,489
R01 · FY2025 · AR
Translational Basic and Clinical Research Training in Rheumatology$310,474
T32 · FY2025 · AR · contact PI
Stopping Hydroxychloroquine In Elderly Lupus Disease (SHIELD)$1,308,540
R01 · FY2024 · AR
DP22-002 HEALTH: Harnessing Epidemiology to Advance Lupus Treatment and Health$950,000
U01 · FY2024 · DP
Mechanisms of DNA-Specific Autoimmunity in Systemic Lupus Erythematosus$717,625
R01 · FY2024 · AR
Digital Pathology and Computational Image Analysis for Lupus Nephritis$717,573
R01 · FY2024 · AR
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)$632,925
R01 · FY2024 · HD · contact PI
Lupus Omics Cutaneous Kidney Investigative Team (LOCKIT)$600,000
UC2 · FY2024 · AR · contact PI
Translational Basic and Clinical Research Training in Rheumatology$304,489
T32 · FY2024 · AR · contact PI
Lupus Omics Cutaneous Kidney Investigative Team (LOCKIT)$288,149
UC2 · FY2024 · AR · contact PI
Lupus Omics Cutaneous Kidney Investigative Team (LOCKIT)$1,600,000
UC2 · FY2023 · AR · contact PI
Stopping Hydroxychloroquine In Elderly Lupus Disease (SHIELD)$1,557,772
R01 · FY2023 · AR
HEALTH: Harnessing Epidemiology to Advance Lupus Treatment and Health$899,999
U01 · FY2023 · DP
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)$697,597
R01 · FY2023 · HD · contact PI
Lupus Omics Cutaneous Kidney Investigative Team (LOCKIT) - Pain Supplement$356,561
UC2 · FY2023 · AR · contact PI
Translational Basic and Clinical Research Training in Rheumatology$240,465
T32 · FY2023 · AR · contact PI
Lupus Omics Cutaneous Kidney Investigative Team (LOCKIT)$1,053,670
UC2 · FY2022 · AR · contact PI
HEALTH: Harnessing Epidemiology to Advance Lupus Treatment and Health$899,999
U01 · FY2022 · DP
Platelet Activity and Vascular Health in Systemic Lupus Erythematosus$763,974
R01 · FY2022 · HL
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)$703,241
R01 · FY2022 · HD · contact PI
Mechanisms of DNA-Specific Autoimmunity in Systemic Lupus Erythematosus$493,805
R01 · FY2022 · AR
Translational Basic and Clinical Research Training in Rheumatology$310,788
T32 · FY2022 · AR · contact PI
Translational Center of Molecular Profiling in Preclinical and Established Lupus (COMPEL)$1,297,885
P50 · FY2021 · AR · contact PI
Platelet Activity and Vascular Health in Systemic Lupus Erythematosus$917,330
R01 · FY2021 · HL
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)$724,814
R01 · FY2021 · HD · contact PI
Mechanisms of DNA-Specific Autoimmunity in Systemic Lupus Erythematosus$481,823
R01 · FY2021 · AR
Translational Basic and Clinical Research Training in Rheumatology$313,303
T32 · FY2021 · AR · contact PI
Administrative Core$162,557
P50 · FY2021 · AR · contact PI
Translational Center of Molecular Profiling in Preclinical and Established Lupus (COMPEL)$1,319,112
P50 · FY2020 · AR · contact PI
Platelet Activity and Vascular Health in Systemic Lupus Erythematosus$798,104
R01 · FY2020 · HL
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)$780,938
R01 · FY2020 · HD · contact PI
Mechanisms of DNA-Specific Autoimmunity in Systemic Lupus Erythematosus$496,333
R01 · FY2020 · AR
Multi-Ethnic Translational Research Optimization (METRO) Lupus Consortium$481,619
UH2 · FY2020 · AR · contact PI
Translational Basic and Clinical Research Training in Rheumatology$303,342
T32 · FY2020 · AR · contact PI
Withdrawal of Hydroxychloroquine in Elderly Lupus Patients: Planning Grant$226,208
R34 · FY2020 · AR · contact PI
Platelet Activity and Vascular Health in Systemic Lupus Erythematosus$223,133
R01 · FY2020 · HL
Administrative Core$200,606
P50 · FY2020 · AR · contact PI
Translational Center of Molecular Profiling in Preclinical and Established Lupus (COMPEL)$1,340,033
P50 · FY2019 · AR · contact PI
Multi-Ethnic Translational Research Optimization (METRO) Lupus Consortium$1,117,810
UH2 · FY2019 · AR · contact PI
Platelet Activity and Vascular Health in Systemic Lupus Erythematosus$823,765
R01 · FY2019 · HL
Mechanisms of DNA-Specific Autoimmunity in Systemic Lupus Erythematosus$494,008
R01 · FY2019 · AR
Translational Basic and Clinical Research Training in Rheumatology$280,888
T32 · FY2019 · AR · contact PI
Preventive Approach to Congenital Heart Block with Hydroxychloroquine (PATCH)$277,079
R01 · FY2019 · HD · contact PI
Withdrawal of Hydroxychloroquine in Elderly Lupus Patients: Planning Grant$266,753
R34 · FY2019 · AR · contact PI
Administrative Core$164,736
P50 · FY2019 · AR · contact PI
Multi-Ethnic Translational Research Optimization (METRO) Lupus Consortium$105,524
UH2 · FY2019 · AR · contact PI
Translational Center of Molecular Profiling in Preclinical and Established Lupus (COMPEL)$1,368,593
P50 · FY2018 · AR · contact PI
Multi-Ethnic Translational Research Optimization (METRO) Lupus Consortium$944,516
UH2 · FY2018 · AR · contact PI
Platelet Activity and Vascular Health in Systemic Lupus Erythematosus$805,604
R01 · FY2018 · HL
Mechanisms of DNA-Specific Autoimmunity in Systemic Lupus Erythematosus$508,116
R01 · FY2018 · AR
Maternal Autoantibodies: Pathogenesis of Neonatal Lupus$366,120
R37 · FY2018 · AR · contact PI
Translational Basic and Clinical Research Training in Rheumatology$292,700
T32 · FY2018 · AR · contact PI
Preventive Approach to Congenital Heart Block with Hydroxychloroquine (PATCH)$275,348
R01 · FY2018 · HD · contact PI
FcRIIA, Platelet Activity, and Vasculopathy in Systemic Lupus Erythematosus$186,450
R21 · FY2018 · AR · contact PI
Genetics and the Microbiome in Anti-Ro Preclinical and Established Autoimmunity$176,880
R21 · FY2018 · AR · contact PI
Administrative Core$165,778
P50 · FY2018 · AR · contact PI
Translational Center of Molecular Profiling in Preclinical and Established Lupus (COMPEL)$1,375,590
P50 · FY2017 · AR · contact PI
Multi-Ethnic Translational Research Optimization (METRO) Lupus Consortium$686,349
UH2 · FY2017 · AR · contact PI
Multi-Ethnic Translational Research Optimization (METRO) Lupus Consortium$366,395
UH2 · FY2017 · AR · contact PI
Maternal Autoantibodies: Pathogenesis of Neonatal Lupus$366,120
R37 · FY2017 · AR · contact PI
Preventive Approach to Congenital Heart Block with Hydroxychloroquine (PATCH)$275,348
R01 · FY2017 · HD · contact PI
Genetics and the Microbiome in Anti-Ro Preclinical and Established Autoimmunity$229,460
R21 · FY2017 · AR · contact PI
FcRIIA, Platelet Activity, and Vasculopathy in Systemic Lupus Erythematosus$223,740
R21 · FY2017 · AR · contact PI
Translational Basic and Clinical Research Training in Rheumatology$206,800
T32 · FY2017 · AR · contact PI
Administrative Core$126,826
P50 · FY2017 · AR · contact PI
Multi-Ethnic Translational Research Optimization (METRO) Lupus Consortium$578,905
UH2 · FY2016 · AR · contact PI
Multi-Ethnic Translational Research Optimization (METRO) Lupus Consortium$498,441
UH2 · FY2016 · AR · contact PI
Preventive Approach to Congenital Heart Block with Hydroxychloroquine (PATCH)$272,660
R01 · FY2016 · HD · contact PI
Multi-Ethnic Translational Research Optimization (METRO) Lupus Consortium$169,500
UH2 · FY2016 · AR · contact PI
Multi-Ethnic Translational Research Optimization (METRO) Lupus Consortium$700,001
UH2 · FY2015 · AR · contact PI
Maternal Autoantibodies: Pathogenesis of Neonatal Lupus$366,120
R37 · FY2015 · AR · contact PI
Preventive Approach to Congenital Heart Block with Hydroxychloroquine (PATCH)$284,511
R01 · FY2015 · HD · contact PI
Multi-Ethnic Translational Research Optimization (METRO) Lupus Consortium$700,001
UH2 · FY2014 · AR · contact PI
Maternal Autoantibodies: Pathogenesis of Neonatal Lupus$358,798
R37 · FY2014 · AR · contact PI
Maternal Autoantibodies: Pathogenesis of Neonatal Lupus$205,200
R37 · FY2014 · AR · contact PI
Preventive Approach to Congenital Heart Block with Hydroxychloroquine (PATCH)$84,311
R03 · FY2014 · HD · contact PI
Maternal Autoantibodies: Pathogenesis of Neonatal Lupus$366,120
R37 · FY2013 · AR · contact PI
Maternal Autoantibodies: Pathogenesis of Neonatal Lupus$149,204
R37 · FY2013 · AR · contact PI
Preventive Approach to Congenital Heart Block with Hydroxychloroquine (PATCH)$80,191
R03 · FY2013 · HD · contact PI
Maternal Autoantibodies: Pathogenesis of Neonatal Lupus$354,404
R37 · FY2012 · AR · contact PI
Preventive Approach to Congenital Heart Block with Hydroxychloroquine (PATCH)$84,500
R03 · FY2012 · HD · contact PI
Maternal Autoantibodies: Pathogenesis of Neonatal Lupus$354,404
R37 · FY2011 · AR · contact PI
Maternal Autoantibodies: Pathogenesis of Neonatal Lupus$369,171
R37 · FY2010 · AR · contact PI
RESEARCH REGISTRY FOR NEONATAL LUPUS$285,233
N01 · FY2010 · AR · contact PI
Maternal Autoantibodies: Pathogenesis of Neonatal Lupus$372,900
R37 · FY2009 · AR · contact PI
RESEARCH REGISTRY FOR NEONATAL LUPUS$285,233
N01 · FY2009 · AR · contact PI
Maternal Autoantibodies: Pathogenesis of Neonatal Lupus$372,350
R37 · FY2008 · AR · contact PI
PREDICTORS OF PREGNANCY OUTCOMES IN SLE AND APS$4,874
M01 · FY2008 · RR · contact PI
PREVENTATIVE IVIG THERAPY FOR CONGENITAL HEART BLOCK (PITCH)$135
M01 · FY2008 · RR · contact PI
Maternal Autoantibodies: Pathogenesis of Neonatal Lupus$326,649
R01 · FY2007 · AR · contact PI
PREDICTORS OF PREGNANCY OUTCOMES IN SLE AND APS$7,495
M01 · FY2007 · RR · contact PI
ACR RE-CLASSIFICATION OF SLE CRITERIA (A ROSE)$394
M01 · FY2007 · RR · contact PI
Maternal Autoantibodies: Pathogenesis of Neonatal Lupus$336,405
R01 · FY2006 · AR · contact PI
PREDICTORS OF PREGNANCY OUTCOMES IN SLE AND APS$16,367
M01 · FY2006 · RR · contact PI
UNDERSTANDING THE SELENA TRIAL: ESTROGEN IN LUPUS$2,339
M01 · FY2006 · RR · contact PI
RESEARCH REGISTRY FOR NEONATAL LUPUS-2642271C-2642271C$0
N01 · FY2006 · AR · contact PI
Maternal Autoantibodies: Pathogenesis of Neonatal Lupus$330,000
R01 · FY2005 · AR
PREDICTORS OF PREGNANCY OUTCOMES IN SLE AND APS$4,774
M01 · FY2005 · RR
Maternal Autoantibodies: Pathogenesis of Neonatal Lupus$330,000
R01 · FY2004 · AR
STUDY OF DEXAMETHASONE IN NEONATAL LUPUS CHB$275,828
R01 · FY2004 · AR
Safety of Estrogen in Lupus Erythematosus$64,588
U01 · FY2004 · AR
Predictors of Pregnancy Outcomes in SLE and APS$1,778
M01 · FY2004 · RR
STUDY OF DEXAMETHASONE IN NEONATAL LUPUS CHB$405,094
R01 · FY2003 · AR
Maternal Autoantibodies--Pathogenesis of Neonatal Lupus$330,000
R01 · FY2003 · AR
Safety of Estrogen in Lupus Erythematosus$1,019,677
U01 · FY2002 · AR
STUDY OF DEXAMETHASONE IN NEONATAL LUPUS CHB$393,292
R01 · FY2002 · AR
MATERNAL AUTOANTIBODIES--PATHOGENESIS OF NEONATAL LUPUS$344,132
R01 · FY2002 · AR
Safety of Estrogen in Lupus Erythematosus$1,000,306
U01 · FY2001 · AR
STUDY OF DEXAMETHASONE IN NEONATAL LUPUS CHB$381,840
R01 · FY2001 · AR
MATERNAL AUTOANTIBODIES--PATHOGENESIS OF NEONATAL LUPUS$334,490
R01 · FY2001 · AR
SAFETY OF ESTROGEN IN LUPUS ERYTHEMATOSUS- NAT'L ASSESS'$658,232
U01 · FY2000 · AR
STUDY OF DEXAMETHASONE IN NEONATAL LUPUS CHB$408,216
R01 · FY2000 · AR
MATERNAL AUTOANTIBODIES--PATHOGENESIS OF NEONATAL LUPUS$325,117
R01 · FY2000 · AR
RESEARCH REGISTRY FOR NEONATAL LUPUS$147,627
N01 · FY2000 · AR
SAFETY OF ESTROGEN IN LUPUS ERYTHEMATOSUS--NATIONAL ASSESSMENT$0
M01 · FY2000 · RR
SAFETY OF ESTROGEN IN LUPUS ERYTHEMATOSUS--NATIONAL ASSESSMENT$0
M01 · FY2000 · RR